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Abstract : 
Factors associated with syringe sharing differ between women and men; however, it is 
uncertain whether these hold within the setting of a single injection episode. A 
questionnaire eliciting information about the last injection episode with others present 
was administered to participants in a cohort of Montréal injection drug users (IDUs). 
Logistic regression was used to identify correlates of syringe sharing and to test 
potential gender differences in relation to syringe sharing. Data from 467 participants 
revealed significant differences between men and women with regard to situational 
factors; however, the relationships between situational factors and syringe sharing did 
not vary according to gender. In multivariate models including both genders, syringe 
sharing was associated with various attributes of other IDUs who were present as well 
as alcohol use during that specific episode. These results highlight the relevance of 
situational factors in injection drug use activity, regardless of gender. 
Key words : Injection drug users, HIV, gender, event analysis 
Introduction 
The population of injection drug users (IDUs) recruited in prevention studies is 
predominantly male (Hagan et al., 2007). Results from most studies cannot be easily 
generalized to women. Researchers have recently increased their attention to potential 
gender differentials among IDUs. Such research has the potential to determine whether 
the factors associated with syringe sharing and human immunodeficiency virus (HIV) 
infection are similar or differ between genders. 
Numerous differences have been identified between the characteristics and 
behaviors of male and female IDUs. For example, female IDUs tend to be younger, 
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more likely to engage in sex work, and more likely to inject heroin versus cocaine than 
male IDUs (Breen et al., 2005; Lum et al., 2005). Freeman et al. (1994) highlighted the 
particular risks associated with having a drug-using sex partner; females in their sample 
were significantly more likely than males to report injecting with a sex partner in the 
previous six months, having a sex partner who is also an IDU, and having a sex partner 
inject them after injecting himself. Further, higher proportions of female IDUs than male 
IDUs appear to share syringes with their partners (Frajzyngier et al., 2007; Lum et al., 
2005; Platt et al., 2005; Sherman et al., 2001). Females have also been found more 
likely to be injected by another IDU (Evans et al., 2003). Most of this research has used 
measures of behavior collected through questionnaires pertaining to events that occur 
over the course of the three or six months preceding the survey.  
Cross-sectional and prospective studies have indicated that while characteristics 
of the interpersonal relationships between injection partners are universally important 
determinants of syringe sharing, having an injection partner who is also a sex partner or 
spouse is particularly predictive of syringe sharing among female IDUs (Evans et al., 
2003; Fitzgerald et al., 2007; Sherman et al., 2001; Tortu et al., 2003). In a multivariate 
analysis of the circumstances surrounding initiation into injection drug use among young 
IDUs, Frajzyngier et al. (2007) extended this finding, observing two factors related to 
social interaction (being initiated by a sex partner, and having at least two other people 
present) that were associated with syringe/injection equipment sharing among women, 
but not among men. Additionally, the results of qualitative and quantitative studies 
converge in indicating that sex work is a significant risk factor for women who inject 
(Cruz et al., 2007; Platt et al., 2005). One study suggested that alcohol use may be one 
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factor that is a determinant of syringe sharing among men but not among women 
(Sherman et al., 2001).  
Although differences between women and men in the factors associated with 
syringe sharing are becoming evident, it is uncertain whether these carry over into the 
context of a single injection episode, or event. Event-level research involves questioning 
participants about the circumstances and behaviors related to a single “incident” or set 
of incidents that presented an opportunity for high-risk behavior, as opposed to asking 
about factors that might have occurred at multiple times over the months preceding a 
survey. Event-level analyses offer several noteworthy advantages to analyses of 
behaviors expressed over several months. For example, they can strengthen the basis 
for causal inference when investigating correlates of risky behavior as they ensure that 
the risky behavior occurred at the time of a specific event (Leigh, 2002). They also allow 
examination of relevant variables concerning situational context (e.g., location, or time 
of the day) and the attributes of the sex or injection drug use partners involved in an 
episode, details that may be difficult for participants to recall when being asked about 
behaviors that might have occurred on multiple occasions over several months. Finally, 
they can yield greater accuracy in responses and reduce cognitive burden on the 
respondent by focusing on a particular occasion (Ross et al., 1993).  
Application of event-level methodology in IDU research is novel. Rhodes (2002) 
has suggested shifting our focus in IDU research to specific risk environments, or 
places and times where individuals are more likely to engage in harmful behavior. This 
challenge is justified by a growing body of evidence which emphasizes that HIV 
prevention strategies focusing solely on the attributes of the individual IDU are less 
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successful than those which account for contextual influences (Rhodes, 2002). 
Accordingly, a recent study by Koester et al. (2005) describes interviewing heroin users 
specifically about their “last injection episode”. These authors noted two factors which 
influenced drug preparation behaviors during injection preparation: the location of the 
episode, and the quantity of heroin injected. Participants whose last episodes occurred 
in locations without privacy (e.g., alleys, cars, or parks) and where there was one 
quarter gram or less of heroin present were more likely to report the common use of a 
cooker. Similarly, location and presence of a dopesick IDU, in addition to years of 
injecting history, were independently associated with use of a formerly used, non-
bleached syringe for drug preparation. Likewise, Tortu et al. (2003) used event-level 
methodology, collecting detailed information about participants’ “most recent injection 
event” to identify individual, dyadic, and situation-specific determinants of injection-
related risk during these events. After interviewing 185 women, they found that injecting 
with someone the participant had injected with previously, and injecting with a spouse or 
primary partner, were associated with sharing syringes, other injection equipment, or 
drugs, after adjusting for other factors. 
In 2004, we began administering a questionnaire about recent injection episodes 
to participants of an ongoing longitudinal study of active IDUs in Montréal, Canada. An 
extensive syringe exchange program has been well-established for more than ten years 
in Montréal; unlimited syringes are legally and widely available either free through 
exchange programs or for a nominal fee throughout the city, with access sites situated 
in the places where they are most needed (Bruneau et al., 2008). In spite of the 
availability of syringe exchange, Montréal surveillance data have shown an increase in 
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the incidence of HIV from 3.5 cases per 100 person-years between 1998 and 2002 to 
4.9 cases per 100 person-years between 2003 and 2006 (Secteur Vigie et Protection, 
2006). There has also been an increase in the incidence of hepatitis C, from 26 cases 
per 100 person-years from 1997-2003, to 55 cases per 100 person-years from 2003-
2006 (Secteur Vigie et Protection, 2006). These data illustrate the need to continually 
fine-tune and update our understanding of the context of risk among IDUs. In this report, 
we evaluate gender differences with regard to situational correlates of syringe sharing 
during high-risk injection episodes. 
Methods 
Participants 
The Saint-Luc Cohort (Montréal) is an ongoing dynamic cohort of active IDUs, 
initiated in 1988. To enter, an individual must be at least 18 years old, residing in the 
Montréal area and an active injection drug user for the six months prior to entry. 
Participants return to the study site at six month intervals for administration of a 
behavioral questionnaire and serological testing. Baseline and follow-up questionnaires 
elicit detailed information about sociodemographic characteristics, history of drug use, 
current drug use, injection behavior, acquisition of syringes, and sexual behavior. 
Questionnaires are administered by trained interviewers face-to-face with IDUs in a 
confidential setting. Participants receive fifteen Canadian dollars per visit as 
compensation for their time and contribution. Further details about the Saint-Luc cohort 
are described elsewhere (Bruneau et al., 2001). 
Measures 
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In 2004, an auxiliary questionnaire was developed to obtain more detailed 
information about participants’ last episode of injection. The questionnaire was a 
modified version of that developed by Tortu et al. (2003). It was translated to French 
and back-translated to English for verification. In its original form the instrument was 
designed to include a series of “analogous” items for which a measure of agreement of 
99% was obtained on 22 pairs of analogous items (Tortu et al., 2003). Questions in the 
instrument pertain to the circumstances of the injection episode (location, time, and 
number of persons present), attributes of each person present during the episode (age, 
sex, relationship with index participant, prior sexual cohabitation, and injection drug use 
experiences shared between the index participant and others present), behaviors of, 
and in relation to, each person present (syringe sharing, equipment sharing, and syringe 
lending), and specific items concerning drugs that were used (injection and non-
injection drug use as well as source of money used to purchase drugs).  
This questionnaire was administered at each visit to each participant answering 
“yes” to the following question: “In the past four weeks, did you inject yourself with 
someone who was injecting at the same time?” Only the first, completed questionnaire 
that met the following inclusion criteria for each participant was included in the present 
analysis: at least one other person present injected, the episode occurred at a single 
location, and the episode occurred within four weeks of the study visit date. Bilingual 
research team members were available to ensure interviewing in either French or 
English. All participants gave their informed consent.  
The outcome of interest was answering “yes” to the question, “During the 
episode did you use a syringe that had been used by another person?” (hereafter 
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referred to as “syringe sharing”). Syringe sharing has been established as the main 
source of HIV transmission among IDUs (Nicolosi et al., 1990). Participants were also 
asked whether they shared other injection equipment, such as mixing containers, 
cookers, water, etc., during the episode. This, however, is a separate behavior, less 
reliably recalled (Stimson et al., 1998) and not the focus of the present study.  
To identify episode-specific situational factors associated with syringe sharing, 
we extracted data from the general questionnaire completed on the same date as the 
auxiliary questionnaire, and from the auxiliary questionnaire itself. A conceptual 
framework by Rhodes (2002) was used as a starting point to inform a more specific 
focus on situational influences in the context of a single injection episode. Rhodes 
discusses the risk environment as the social or physical space in which both micro 
factors (e.g., interpersonal relationships, peer group influence, or the immediate setting 
in which drugs are used) and macro factors (e.g., laws and economies that produce and 
relegate risk) interact to affect the likelihood of injection drug-related harm. Based on 
this framework as well as related current literature (Koester et al., 2005; Tortu et al., 
2003), categories of relevant variables hypothesized to be related to risk behavior 
during an injection episode with other IDUs were selected for analysis (Table I). 
Given that only 13% of participants reported more than one other person present 
during the episode, variables relating to other persons present during an episode were 
dichotomized: if at least one other person present had the attribute of interest (e.g., 
being female) the participant was coded as “positive,” regardless of whether others 
present also had that attribute. These attributes were treated as having a situational 
effect on participants’ risk of syringe sharing whether present in one injection partner or 
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many. A variable to indicate whether respondents had a relevant intimate relationship 
was created and defined as ever having had sex with and ever having lived with another 
person who was present during the episode. This combination, although not accounting 
for the time period for each behavior, was considered to be a better indication of 
intimate partnership than each individual component because each individual 
component could carry other meanings (having had sex could indicate a casual sexual 
relationship; and having lived together could indicate being roommates). 
Data analyses 
Descriptive analyses were used to characterize the data. Comparisons of 
characteristics (including the outcome) between men and women were examined using 
a two-sided t-test for independent samples for continuous data and a chi-square test for 
grouped data.  
Logistic regression was used to identify situational predictors of syringe sharing 
according to gender and for the overall sample. Two strategies were employed to 
evaluate an effect of gender. First, sub-sets of the sample were stratified by gender, and 
the effects of independent variables were compared across strata. Secondly, 
independent variables associated with syringe sharing and statistically significant at a 
probability value of 0.05 in univariate analyses were entered one by one into bivariate 
models including gender. Multiplicative interaction terms (containing both gender and 
the independent variable under examination) were added to these models, and potential 
interactions assessed; any added interaction term with a Wald statistic significant at a 
probability value of 0.10 was considered indicative of gender-specific variation. 
Variables that remained statistically significant at p=0.10 in multivariate models were 
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considered for inclusion in final models. Covariate pairs were initially examined for 
correlation, and for collinear pairs only one of the variables was included in a 
multivariate model. Age is known a priori to be an important influence and was included 
in all models (Miller et al., 2007). Gender, as a variable of primary interest, was also 
included in all models based on the full cohort. Model-building procedures were based 
on those described in Hosmer and Lemeshow (2000). All statistical analyses were done 
using R version 2.4.1 (2006).  
Results 
General characteristics 
Of 851 cohort participants who presented for a visit between November 9, 2004 
and March 16, 2007, 467 (54.9%) completed an auxiliary questionnaire about their most 
recent episode of injection. The remaining 384 participants did not report injecting with 
others in the previous four weeks. Of these, 382 (81.8%) were male, 84 (18.0%) were 
female, and 1 (0.2%) was transgender (this participant was excluded from analyses that 
compared genders and was treated as a missing value for the gender variable in 
analyses of the full cohort). Eighty-five percent of the participants spoke French as their 
first language, 40.7% reported living in some form of unstable housing (a shelter, hotel, 
on the street, or in prison), 23.2% had been incarcerated in the previous six months, 
and 16.5% had completed education beyond a high school degree. Seven percent were 
HIV-positive and 72.6% were hepatitis C-positive (confirmed by laboratory testing). 
The range of the length of episodes of drug use reported by participants was 5 
minutes to 6 days (mean: 5.5 hours; median: 1 hour). While the majority of episodes 
lasted one hour or less, there was a wide distribution of their lengths with 15.0% of 
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episodes lasting longer than 10 hours. Eighty-seven percent of participants reported 
only one other person present during the episode, 11.3% reported two or three other 
persons present, and the remaining 1.9% reported between four and eight other 
persons present.  
Ninety-one (19.5%) participants injected only heroin during the episode. Three 
hundred two (64.7%) injected only cocaine, 13 (2.8%) injected heroin and cocaine, and 
61 (13.1%) injected another drug (alone or in combination with cocaine and heroin). 
Injection of heroin alone was compared with injection of any other drug or combination 
of drugs in analyses. 
INSERT TABLE I HERE 
Comparison of characteristics by gender 
Comparisons between men and women are shown in Table II. Compared with 
women, men were on average older, and less likely to engage in prostitution, inject with 
an intimate partner, and inject only heroin during an episode; they were more likely to 
inject with a female and use non-injection drugs such as alcohol or cocaine. More 
women shared syringes than men; however, this difference was not statistically 
significant.  
INSERT TABLE II HERE 
Comparison of correlates of syringe sharing by gender 
Univariate analysis of the entire sample revealed several significant correlates of 
syringe sharing; gender-stratified results are presented in Table III. Stratification 
indicated generally similar effects in point estimates for men and women, with one 
noteworthy exception. Having more than one other person present during the episode 
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was associated with higher risk of syringe sharing among men, but no such association 
was apparent for women. No statistically significant interactions were observed between 
gender and the variables used in analyses, as shown in Table III. 
INSERT TABLE III HERE 
Multivariate correlates of syringe sharing 
Multivariate estimates for the overall cohort are presented alongside crude 
estimates in Table IV. The magnitude and significance of most correlates of syringe 
sharing in univariate analyses changed little when other factors were accounted for in 
multivariate models, with the some exceptions. A “protective” effect of injecting only 
heroin became stronger and statistically significant when adjusting for other factors. 
Also, the effect of female gender in the univariate model was attenuated in the full 
multivariate model.  
INSERT TABLE IV HERE 
Discussion 
The results of this study indicate that, in a single injection episode, the situational 
correlates of sharing syringes with injection partners did not differ between men and 
women, despite absolute gender differences in many such factors associated with 
participation in that injection episode. For example, injecting with an intimate partner 
was associated with a nearly equivalent odds of syringe sharing for men (odds ratio 
2.20) and women (odds ratio 2.40). Women, however, were almost 3 times as likely to 
inject with an intimate partner when injecting with others as compared to men. Likewise, 
alcohol use increased the risk of syringe sharing by similar magnitudes for men (odds 
ratio 2.20) and women (odds ratio 2.27), but men were more likely to use alcohol during 
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the episode (27% vs. 14%). The effects of one factor did indeed differ (i.e., having more 
than one other person present); however, this factor was not associated with syringe 
sharing in multivariate models. This suggests that the aforementioned differences 
between men and women IDUs widely referenced in the IDU literature derive not from a 
difference in the influences of situational factors on risk, but rather, from the fact that 
many of these risky situational factors arise more frequently among women than among 
men. Indeed, the two risk factors most strongly associated with sharing, i.e., the 
presence of an intimate partner, or a person in whom the participant places “confidence”, 
were also those reported more frequently by women than by men in our study. 
Nevertheless, the finding that episode-specific situational correlates of syringe 
sharing do not vary according to gender is unanticipated in light of a growing body of 
research that suggests gender differences and calls for more attention to these issues 
in research on IDUs. In particular, the lack of a gender difference in syringe sharing 
associated with injecting with an intimate partner contrasts with other reports indicating 
that injecting with a sex partner or spouse is more strongly associated with syringe 
sharing among women than among men (Evans et al., 2003; Fitzgerald et al., 2007). 
There are several possible explanations for this discrepancy. Use of an event-level 
methodology in this study means, by definition, that injection with an intimate partner 
occurred during the same episode in which a syringe was shared. In contrast, most 
other studies of IDUs use global measures, i.e., injection with a sex partner at some 
point during the previous three months and syringe sharing at some point during the 
previous three months (Evans et al., 2003). Such general associations allow for syringe 
sharing to have occurred at episodes different from the one in which the intimate partner 
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was present. Alternatively, the circumstances of a binge may be powerful enough to 
overwhelm the gender differences detected in other studies. As described by Miller et al. 
(2006), binge behavior differs in significant ways from normal patterns of consumption. 
Our use of an event-level approach also means that we could not account for the 
frequency of injecting. Thus, if women are equally likely as men to share syringes with 
an intimate partner at a given episode but inject more frequently, then this may also 
help explain the discrepant findings of our study. Our study furthermore differed from 
others in the definition of “intimate partner,” which we defined as someone with whom 
the participant had lived and had sex.  
Notwithstanding the absence of an effect modifying influence of gender, our 
analysis highlights several episode-specific correlates of syringe sharing. The seemingly 
contradictory effects where having confidence in one’s injection partners “protects” 
against sharing, while having had an intimate relationship with injection partners 
“increases” the risk of sharing, might be partially explained by the qualitative research of 
Des Jarlais et al. (2004) and others (Friedman et al., 2007). Extensive care-taking within 
groups or dyads of IDUs often ensures that syringes are not shared between HIV-
positive and HIV-negative individuals. Thus, having confidence in partners may be a 
marker of trust that one’s partners will not allow risky behavior such as syringe sharing 
during an injection episode. By contrast, having had an intimate relationship with 
partners may be a marker of serostatus disclosure between partners, thus allowing 
sharing within concordant dyads. The pronounced influence of interpersonal factors was 
also demonstrated by the association between use of new syringes by other IDUs and 
syringe sharing of the index IDU. In episodes where all other IDUs present used a new 
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syringe for every injection, the participant was five-times less likely to share syringes 
(OR 0.18, 95% CI 0.10, 0.34). This is a powerful reminder of value of policies that 
ensure ample accessibility and supply; provision of clean syringes affects not only the 
behaviors of the syringe recipients but those of their peers as well. 
The “protective” effect of injecting in a public place was surprising, given other 
research—including the event-level study by Koester et al. (2005)—in which injecting in 
a public place was associated with a greater risk of syringe sharing (Latkin et al., 1994; 
Small et al., 2007). As explained by Koester et al. (2005), this finding has generally 
been attributed to the notion that IDUs injecting in places where privacy and safety are 
compromised seek to inject as quickly as possible. Our discrepant results may be 
explained by cultural differences between different settings (i.e., Montréal as compared 
with other cities). The “protective” effect of injecting in public places in this study also 
points to the complexity of social relationships during injection episodes. Injection 
partners of participants who injected in public places were twice as likely to be strangers 
or acquaintances as the partners of participants who injected in a home or rented room 
(data not presented). Individuals may be less willing to share syringes with unfamiliar 
partners.  
Several studies have drawn attention to the prevalent use of illicit income-
generating activities such as drug dealing and sex work by IDUs to cover the costs of 
injection drugs, and some have related these activities to syringe sharing (Bourgois, 
1998; De Beck et al., 2007; Sherman and Latkin, 2002). The association between illegal 
activities (especially activities other than prostitution, which mostly relate to the 
movement and sale of drugs) and syringe sharing found in this study strengthens prior 
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research in this area. Other findings from this study are not novel (e.g., alcohol use as a 
risk factor and injecting heroin exclusively as a protective factor for syringe sharing); 
however, they add to the strength of existing evidence by confirming the relationship 
within a particular episode (Hudgins et al., 1995; Stein et al., 2000; Stein et al., 2002).  
The most salient correlates found in our analyses relate to interpersonal factors.  
Other studies have similarly noted the important influence of IDU networks on individual 
risk-taking (Koester et al., 2005; Lakon et al., 2006). This highlights the need to focus 
interventions on relationships among IDUs. Risk reduction counseling should account 
for emotional reliance on intimate partners and possibly allow for joint counseling 
sessions that enable an exploration of how partners affect each other’s behavior during 
an injection episode.  
Future event-level studies may expand on what has been examined in this study, 
potentially by asking participants to specify the temporality of non-injection drug use, 
alcohol use, and injection drug use within an episode. In this study there was a two-fold 
increase in the likelihood of sharing syringes among those who used alcohol, but it is 
uncertain whether alcohol use preceded syringe sharing, thus limiting the capacity for 
causal inference. Future research is encouraged to explore the complex relationship 
between injecting in a public space and sharing syringes, as well as the powerful 
influence of interpersonal factors, such as history of intimacy.  
The limited number of female participants precluded stratified multivariate 
analyses for each gender separately. This lack of power is an alternative explanation for 
the fact that we did not detect different relationships between men and women. We 
attempted to partially overcome limited statistical power by testing interactions with 
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gender, rather than engaging in further analyses stratified by gender.  
Because obtaining answers to detailed questions about a particular episode can 
be problematic, especially if an interviewee was intoxicated at the time of the episode, 
our data are subject to reporting errors. Recall errors were probably minimized, however, 
as participants were interviewed only about episodes occurring within the previous four 
weeks. Limited information was available on the psychometric properties of the 
questionnaire, and we were unable to provide a full assessment of its validity and 
reliability. An unclear and problematic issue is that we cannot be sure how different 
individuals interpreted the concept of “having confidence in others.” This will be 
addressed in future refinement of the questionnaire. 
Being injected by someone else has been reported to correlate both with syringe 
sharing (Unger et al., 2006) and being female (Evans et al., 2003). Thus, selecting for 
participants who injected with someone who was injecting at the same time may have 
introduced the effect of inflating the association between being female and sharing 
syringes. 
We opt for caution in generalizing our results. A single episode is not necessarily 
representative of general exposures over a longer period of drug use, and the Saint-Luc 
Cohort may not be representative of IDU populations outside of primarily French-
speaking Montréal. Participants included in these analyses were seen on average for 
2.5 study visits prior to completing the questionnaire. On this basis it is possible that the 
overall risks of IDUs in the larger population were underestimated as some participants 
may have reduced their sharing behavior over the course of receiving study-related 
counseling. This limitation, however, implies that we may have focused on risk 
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behaviors less amenable to change through current prevention strategies, for which 
improved understanding is especially important. We also acknowledge that the subset 
of participants included in this study may differ from the larger Saint-Luc cohort. Among 
the 384 participants excluded from our analyses, 46.2% never injected in the company 
of other IDUs over the prior six months. This finding is not unexpected, given the 
inclusion criteria for this study. This proportion did not significantly differ by gender 
(46.4% among men; 44.4% among women). 
Our results provide evidence for the importance of situational correlates of 
episode-specific syringe sharing among injection drug users. Studies that question 
participants about habitual behaviors over the course of six-month periods or lifetimes 
can provide only general information about factors associated with syringe sharing.  
Complementary research on specific episodes allowing for coding of outcomes and 
exposures at the same point in time can add substantive, and more specific, knowledge 
about situational factors that affect injection behavior. Together, these two approaches 
can help refine our understanding of differences between men and women IDUs by 
considering both the frequencies and effects of the situational risk factors for syringe 
sharing among the two groups. If gender differences are important with regard to 
relationships between syringe sharing and the correlates of injection episodes, they may 
be overwhelmed in the context of a binge and overemphasized when measured in 
relation to broader periods of time.  
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Table I:  Categories of independent variables hypothesized as relevant to situational behavior 
during a single episode with other injection drug users present 
Category Variables included in analysis 
Circumstances of episode Location of episode (participant’s home, home of 
friend or partner, rented room, or public place); 
length of episode; total number of injections by 
participant during episode; number of persons 
present during episode 
Availability of syringes All other persons present had a new syringe for 
every injection 
Injection drug used Heroin only versus cocaine (alone or with heroin) 
Non-injection drugs used Alcohol; cocaine 
Source of money for drugs Legal activities as compared with prostitution or 
other illegal activities 
Relationship with other person(s) present Gender of other person(s); intimacy with other 
person(s); confidence in other person(s); history of 
syringe sharing with other person(s) 
Personal experience Age; time since first injection drug use; engaged in 
prostitution in last six months; Hepatitis C and HIV 
serostatus 
 
 
 
 
Table II: Comparison of characteristics of male and female injection drug users who completed 
questionnaires about most recent episode of injection (men relative to women) 
Variable Men (n = 382) 
% or Mean (SD) 
Women (n = 84) 
% or Mean (SD) 
Difference (95% CI) 
Age, years 38.8 (9.6) 32.7 (10.0) 6.1 (3.7, 8.5) * 
Time since first injection drug use, years 14.3 (9.5) 12.2 (9.1) 2.0 (-0.2, 4.2) 
Length of episode, hours 5.5 (10.6) 5.8 (18.0) -0.3 (-4.4, 3.8) 
Total number of injections by participant during 
episode 5.5 (11.2) 5.2 (16.6) 0.2 (-3.6, 4.0) 
Engaged in prostitution in last six months 8.6 32.1 -23.5 (-34.6, -12.4) * 
HIV-positive at study visit 8.1 2.4 5.7 (0.8, 10.7) * 
Location of episode:    
Participant’s home 34.2 50.6 -16.4 (-28.9, -3.8) * 
Home of friend, partner, or family member 20.5 16.9 3.6 (-6.2, 13.4) 
Rented room or hotel 7.5 2.4 5.1 (0.1, 10.1) * 
Public place 37.7 30.1 7.6 (-4.2, 19.4) 
More than one other person present during 
episode 13.4 13.1 0.3 (-8.0, 8.5) 
Other person(s) present during episode a:    
is female 29.8 17.9 12.0 (1.9, 22.1) * 
is an intimate partner of participant b 17.0 47.6 -30.6 (-42.7, -18.6) * 
is someone in whom participant places 
“confidence” c 55.8 70.2 -14.5 (-26.2, -2.8) * 
has shared syringes with participant prior to 
episode 35.8 56.0 -20.2 (-32.5, -7.8) * 
All other persons present had a new syringe for 
every injection 64.7 64.3 0.4 (-11.3, 12.1) 
Source of money used to provide drugs for    
episode: 
prostitution 5.2 13.1 -7.9 (-16.1, 0.4) 
other illegal activities (not prostitution)  8.9 8.3 0.6 (-6.6, 7.7) 
Non-injection drugs used by participant during 
episode:    
Alcohol 26.7 14.3 12.4 (3.0, 21.8) * 
Cocaine 14.7 8.3 6.3 (-1.3, 13.9) 
Participant injected only heroin during episode 15.2 39.3 -24.1 (-35.9, -12.3) * 
Participant used a syringe that had already been 
used by another person during episode 16.0 20.2 -4.3 (-14.3, 5.8) 
 
NOTE: Student’s t-test for independent samples used to compare means. Chi-square test used to 
compare proportions.  
LEGEND: SD, standard deviation. CI, confidence interval. * denotes significant confidence interval at 
alpha value of 0.05. a Only one other person was present during episode for 87% of participants. For 
those with more than one other person present, variables represent characteristic of at least one other 
person. b Intimate partner is defined as someone participant has lived with and had sex with. c Confidence 
is defined as answering 7 or more to the question, “On a scale of 1 to 10, how much confidence do you 
have in this person? 1 = no confidence, 10 = total confidence.” 
Table III: Results of univariate and bivariate analyses testing effect modification by gender for variables associated with syringe sharing 
during last injection episode 
 Men (n = 382) 
Univariate 
Women (n = 84) 
Univariate 
All (n = 467) 
 
Variable OR (95% CI) OR (95% CI) 
Bivariate 
OR † 
(95% CI) 
Bivariate 
OR with 
interaction 
term ‡ 
(95% CI) 
P-value of 
interaction 
term 
Age, years 1.01 (0.98, 1.04) 1.01 (0.96, 1.07) - - - - - 
Time since first injection drug use, 
years 1.01 (0.98, 1.03) 1.02 (0.96, 1.07) - - - - - 
Length of episode, hours 1.01 (0.99, 1.03) 1.00 (0.97, 1.03) - - - - - 
Total number of injections by 
participant during episode 1.01 (0.99, 1.03) 1.00 (0.96, 1.03) - - - - - 
Engaged in prostitution in last six 
months 1.79 (0.77, 4.17) 1.65 (0.55, 4.93) - - - - - 
Location of episode (reference: home 
of participant):          
Home of friend, partner, or 
family member 0.92 (0.45, 1.90) 0.77 (0.18, 3.28) - - - - - 
Rented room or hotel 0.89 (0.31, 2.56) n/d - - - - - - 
Public place 0.53 (0.27, 1.04) 0.38 (0.10, 1.54) - - - - - 
More than one other person present 
during episode 2.02 (1.00, 4.06) * 0.86 (0.17, 4.40) 1.73 (0.91, 3.29) 0.86 (0.17, 4.40) 0.35 
Other person(s) present during 
episode a:          
is female 1.66 (0.94, 2.94) 1.57 (0.43, 5.71) - - - - - 
is an intimate partner of 
participant b 2.20 (1.16, 4.16) * 2.40 (0.79, 7.26) 2.21 (1.27, 3.82) 2.40 (0.79, 7.26) 0.86 
is someone in whom participant 
places “confidence” c 0.49 (0.28, 0.86) * 0.38 (0.13, 1.15) 0.47 (0.28, 0.77) 0.38 (0.13, 1.15) 0.69 
has shared syringes with 
participant prior to episode 5.29 (2.92, 9.57) * 4.81 (1.26, 18.28) * 5.21 (3.03, 8.96) 4.81 (1.26, 18.28) 0.90 
All other persons present had a new 
syringe for every injection 0.26 (0.15, 0.46) * 0.15 (0.05, 0.50) * 0.24 (0.14, 0.39) 0.15 (0.05, 0.50) 0.42 
Source of money used to provide 
drugs for episode:          
prostitution 2.04 (0.71, 5.89) 1.88 (0.43, 8.21) 1.96 (0.83, 2.74) 1.88 (0.43, 8.21) 0.93 
other illegal activities (not 
prostitution) 2.55 (1.15, 5.69) * 3.75 (0.73, 19.16) 2.75 (1.34, 5.62) 3.75 (0.73, 19.16) 0.68 
Non-injection drugs used by 
participant during episode:          
alcohol 2.20 (1.24, 3.89) * 2.27 (0.59, 8.68) 2.21 (1.31, 3.74) 2.27 (0.59, 8.68) 0.97 
cocaine 1.01 (0.47, 2.18) 0.64 (0.07, 5.66) - - - - - 
Participant injected only heroin during 
episode 0.45 (0.17, 1.18) 0.40 (0.12, 1.37) - - - - - 
 
LEGEND: OR, odds ratio. CI, confidence interval. n/d, not defined due to zero value in one cell. † Model includes variable of interest as well as 
gender; OR presented for variable of interest. ‡ Model includes variable of interest, gender, and multiplicative interaction term between gender and 
variable of interest; OR presented for variable of interest. * denotes significance at alpha level of 0.05. a Only one other person was present during 
episode for 87% of participants. For those with more than one other person present, variables represent characteristic of at least one other person. 
b Intimate partner is defined as someone participant has lived with and had sex with. c Confidence is defined as answering 7 or more to the 
question, “On a scale of 1 to 10, how much confidence do you have in this person? 1 = no confidence, 10 = total confidence.” 
 
Table IV: Results of univariate and multivariate analyses of predictors of syringe sharing during 
last injection episode for cohort participants (n = 467) 
 Univariate Multivariate 
Variable OR (95% CI) OR  (95% CI) 
Age, years 1.01 (0.98, 1.03) 0.99 (0.96, 1.03) 
Gender (female) 1.34 (0.73, 2.43) 1.16 (0.53, 2.56) 
Time since first injection drug use, years 1.01 (0.98, 1.03) - - 
Length of episode, hours 1.01 (0.99, 1.02) - - 
Total number of injections by participant during 
episode 1.01 (0.99, 1.02) - - 
Engaged in prostitution in last six months 1.78 (0.93, 3.37) - - 
Location of episode (reference: home of 
participant):     
Home of friend, partner, or family member 0.87 (0.46, 1.65) 0.92 (0.40, 2.15) 
Rented room or hotel 0.74 (0.27, 2.08) 0.79 (0.23, 2.74) 
Public place 0.48 (0.27, 0.89) * 0.47 (0.22, 1.00) 
More than one other person present during 
episode 1.73 (0.91, 3.29) - - 
Other person(s) present during episode a:     
is female 1.60 (0.95, 2.67) - - 
is an intimate partner of participant b 2.23 (1.32, 3.77) * 2.59 (1.19, 5.64) * 
is someone in whom participant places 
“confidence” c 0.49 (0.30, 0.80) * 0.36 (0.19, 0.66) * 
has shared syringes with participant prior to 
episode 5.21 (3.05, 8.91) * 4.95 (2.60, 9.42) * 
All other persons present had a new syringe for 
every injection 0.24 (0.14, 0.39) * 0.18 (0.10, 0.34) * 
Source of money used to provide drugs for     
episode: 
prostitution 2.06 (0.88, 4.84) 2.57 (0.91, 7.24) 
other illegal activities (not prostitution) 2.75 (1.35, 5.63) * 3.28 (1.35, 7.98) * 
Non-injection drugs used by participant during 
episode:     
alcohol 2.12 (1.26, 3.55) * 2.05 (1.05, 3.98) * 
cocaine 0.93 (0.45, 1.92) - - 
Participant injected only heroin during episode 0.49 (0.23, 1.02) 0.24 (0.09, 0.63) * 
 
LEGEND: OR, odds ratio. CI, confidence interval. n/d, not defined due to zero value in one cell. * denotes 
significance at alpha level of 0.05. a Only one other person was present during episode for 87% of 
participants. For those with more than one other person present, variables represent characteristic of at 
least one other person. b Intimate partner is defined as someone participant has lived with and had sex 
with. c Confidence is defined as answering 7 or more to the question, “On a scale of 1 to 10, how much 
confidence do you have in this person? 1 = no confidence, 10 = total confidence.” 
